Go Pro
LON:UDG

UDG Healthcare (UDG) Share Price, News & Analysis

UDG Healthcare logo

About UDG Healthcare Stock (LON:UDG)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
1.39 million shs
Market Capitalization
£2.72 billion
P/E Ratio
42.48
Dividend Yield
1.17%
Price Target
N/A
Consensus Rating
N/A

Company Overview

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; serialization solutions; and clinical IRT services. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is heaquartered in Dublin, the Republic of Ireland.

Receive UDG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for UDG Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UDG Stock News Headlines

Prescient Healthcare Group Names New CEO
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
CD&R Announces New Partners
See More Headlines

UDG Stock Analysis - Frequently Asked Questions

Shares of UDG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that UDG Healthcare investors own include Carillion (CLLN), Greencore Group (GNC), CRH (CRH), NBT Bancorp (NBTB), Lloyds Banking Group (LLOY), accesso Technology Group (ACSO) and Aviva (AV).

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Healthcare Providers & Services
Sub-Industry
N/A
Current Symbol
LON:UDG
CIK
N/A
Fax
N/A
Employees
9,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
42.48
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
36.63
Current Ratio
1.91
Quick Ratio
1.80

Sales & Book Value

Annual Sales
£1.25 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
11.78
Book Value
GBX 411.10 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
251,883,000
Free Float
N/A
Market Cap
£2.72 billion
Optionable
Not Optionable
Beta
N/A
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (LON:UDG) was last updated on 9/7/2026 by MarketBeat.com Staff.
From Our Partners